BIOLOGICAL SCREENING TO ASSESS NEW POTENTIAL ANTI-CANCER DRUGS

Autor: M. Fazzari ((1), F. Di Blasi (2), M. L. Testa (3), F. Mingoia (3), M. Ippolito (1), A.M. Almerico (1), A. Lauria (1)

Publikováno v: Research and innovation at ISMN-CNR, pp. 154–157, Palermo, 25-26 giugno 2009
info:cnr-pdr/source/autori:M. Fazzari ((1), F. Di Blasi (2), M. L. Testa (3), F. Mingoia (3), M. Ippolito (1), A.M. Almerico (1), A. Lauria (1)/congresso_nome:Research and innovation at ISMN-CNR/congresso_luogo:Palermo/congresso_data:25-26 giugno 2009/anno:2009/pagina_da:154/pagina_a:157/intervallo_pagine:154–157

Development of targeted synthesis of molecules able to act selectively in tumor cells, is currently a hard challenge in the discovery of new less toxic chemotherapeutics agents. The recent discovery of some new cell mecchanisms described at molecular

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::2ce1514fbab40481a843ba6a49711a43
https://publications.cnr.it/doc/265786